Tag:
GSK2118436
Latest Headlines
Latest Headlines
Roche, GSK melanoma drugs in ASCO's "hottest" spotlight
With Roche eager to discuss at ASCO how its closely-watched melanoma drug vemurafenib --in-licensed from Plexxikon--extended the survival of patients in a key study, Bloomberg takes an in-depth look
